Last €54.25 EUR
Change Today 0.00 / 0.00%
Volume 0.0
DNN On Other Exchanges
Symbol
Exchange
OTC US
EN Paris
SIX Swiss Ex
OTC US
BrsaItaliana
Berlin
Mexico
As of 11:30 AM 09/22/14 All times are local (Market data is delayed by at least 15 minutes).

danone (DNN) Snapshot

Open
€54.25
Previous Close
€54.25
Day High
€54.25
Day Low
€54.25
52 Week High
09/23/13 - €57.60
52 Week Low
01/31/14 - €48.70
Market Cap
34.9B
Average Volume 10 Days
62.4
EPS TTM
--
Shares Outstanding
643.8M
EX-Date
05/7/14
P/E TM
--
Dividend
€1.45
Dividend Yield
2.67%
Current Stock Chart for DANONE (DNN)

Related News

No related news articles were found.

danone (DNN) Details

Danone produces and distributes food and beverage products. The company’s Fresh Dairy Products division provides yogurts, fermented fresh dairy products, and specialized dairy products under the Activia, Danonino, Fruchtswerge, Danoninho, Petit Gervais, Danimals, Serenito, Milkuat, Tëma, Actimel, Danacol, Densia, Oikos, Danio, Danette, Fantasia, Danissimo, YoCrunch, Vitalinea, Taillefine, and Ser brands. Its Waters division offers packaged natural, flavored, and vitamin-enriched water under Evian, Volvic, Bonafont, Mizone, Aqua, Fontvella, Lanjarón, Villavicencio, Villa del Sur, and Zywiec Zdroj brands. The company’s Early Life Nutrition division produces and distributes specialized food for babies and young children to complement breast-feeding, as well as solid foods for babies under Aptamil, Nutrilon, Almiron, Gallia, Bebelac, Cow&Gate, Blédina, and Malyutka brands. Its Medical Nutrition division provides specialized food for people receiving medical treatment, babies afflicted with certain illnesses, and frail elderly people. Its products include liquid oral nutritional supplements; hypoallergenic products; oral and feeding tube food products for the dietary treatment of infants and children who are incapable of feeding themselves or suffer from illness related malnutrition; and nutritional products for special medical needs. This division markets its products primarily under the Nutricia brand. The company serves individual consumers, retail chains, and traditional market outlets, as well as specialized distribution channels of hospitals, clinics, and pharmacies. It has operations in Russia, France, the United States, China, Indonesia, Spain, Mexico, Argentina, the United Kingdom, and Brazil. Danone has a strategic agreement with Starbucks to create and develop a line of Dannon-branded fresh dairy products. The company was formerly known as Groupe Danone and changed its name to Danone in April 2009. Danone was founded in 1899 and is based in Paris, France.

104,642 Employees
Last Reported Date: 03/24/14
Founded in 1899

danone (DNN) Top Compensated Officers

Vice Chairman, Chief Executive Officer, Chief...
Total Annual Compensation: €1.4M
Vice Chairman and Deputy General Manager
Total Annual Compensation: €1.4M
Compensation as of Fiscal Year 2013.

danone (DNN) Key Developments

Danone Appoints Emmanuel Faber as Chief Executive Officer

Danone (France) has named Emmanuel Faber as Chief Executive Officer. The change in governance was due to separation of Chairman of the Board and CEO functions. Franck Riboud will remain as Chairman of the Board. The Board also voted to set up its own Strategy Committee. The company also says that as part of the new governance structure, Bernard Hours' mandate as Co-COO was terminated.

Danone Puts Up For Sale Its Smolensky Dairy Plant

Danone (ENXTPA:BN) is planning to sell its Smolensky dairy plant. A representative of Danone in Russia told Interfax that the factory is closing, production at it will be completely stopped in October 2014, and the company is searching for a buyer of this asset. The representative said, "The losses in production for almost all types of products at Smolensky dairy plant following a more than 30% rise in the price of raw milk and an inadequate raw material base in the region makes its future development unpromising."

Hospira Talks With Danone Stall

Hospira Inc. (NYSE:HSP) is talks to buy the medical nutrition unit of Danone (ENXTPA:BN) and use the deal to move its tax domicile abroad have stalled. If a deal with one of the strategic players failed, private equity funds would probably be interested in Danone Medical Nutrition, which offers appealing growth prospects and has exposure to emerging markets, said people familiar with the situation.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
DNN:IM €54.25 EUR 0.00

DNN Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Associated British Foods PLC 2,694 GBp +19.00
Baxter International Inc $71.87 USD -0.67
Fresenius SE & Co KGaA €38.46 EUR -0.28
Kraft Foods Group Inc $56.52 USD -0.39
Mondelez International Inc $34.90 USD -0.77
View Industry Companies
 

Industry Analysis

DNN

Industry Average

Valuation DNN Industry Range
Price/Earnings 27.9x
Price/Sales 1.4x
Price/Book 2.7x
Price/Cash Flow 30.6x
TEV/Sales 0.8x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact DANONE, please visit www.danone.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.